TELA Bio, Inc. - 8-K Filing
TELA Bio reported Q1 2026 revenue of $19.1 million, a 3% increase from the prior year period with unit growth of 13%. The company reiterated full-year 2026 revenue guidance for at least 8% growth over 2025 and expects second-quarter revenue to be approximately $20.0 million. (Items: 2.02 Results of Operations and Financial Condition, 7.01 Regulation FD Disclosure, 9.01 Financial Statements and Exhibits)
Tickers: $TELA